TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Smallpox Vaccines
New smallpox vaccines research reported from University of Kentucky, Medical Department
July 22nd, 2008
According to a study from the United States, "Due to concern over i) expiration of currently available calf-lymph vaccine (Dryvax (R)); ii) calf lymph as a vaccine (bovine spongiform encephalopathy [BSE], other possible contaminations and animal welfare); and iii) use of variola as a weapon for bioterrorism, a new and safer vaccinia-based smallpox vaccine derived from new cell culture-based technology was proposed. Federally funded work by Acambis, Inc. resulted in FDA approval for ACAM2000 in August 2007." "This paper describes the development from conception to FDA approval of the new vaccinia cell cultured-based smallpox vaccine ACAM2000. Data were compiled from...
Source: TB & Outbreaks Week (2008-07-22)
|
